Study S001467

Coronary Flow Reserve Changes After Semaglutide Treatment

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07190144
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 122
Start: 2025-01-07
Primary completion: 2025-08-01
Lead sponsor: Ekrem Bilal Karaayvaz
Conditions: The Study Focused on the Vascular Effects of Semaglutide in Both Diabetic and Non-diabetic Patients; Obesity &Amp; Overweight
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Number of patients who had acute coronary syndrome [From start of the study to 3 months after]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0008068	Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. Lincoff AM, The New England journal of medicine	2023	Randomized trial	PMID 37952131 DOI	registry reference RESULT:37952131
R0022278	Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. Marso SP, The New England journal of medicine	2016	Randomized trial	PMID 27633186 DOI	registry reference RESULT:27633186